Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 839,266 | 717,472 | 680,832 | 584,504 | 520,326 |
| Cost of Goods | 307,741 | 264,307 | 245,094 | 211,006 | 189,869 |
| Gross Profit | 531,525 | 453,165 | 435,738 | 373,498 | 330,457 |
| Operating Expenses | 452,655 | 383,295 | 371,877 | 320,408 | 288,698 |
| Operating Income | 79,611 | 70,177 | 63,955 | 53,096 | 42,628 |
| Interest Expense | 1,921 | 1,328 | 1,015 | 1,718 | 2,128 |
| Other Income | -215 | -300 | -300 | -1,988 | -1,739 |
| Pre-tax Income | 77,475 | 68,549 | 62,640 | 49,390 | 38,761 |
| Income Tax | 25,098 | 22,760 | 20,363 | 15,951 | 12,603 |
| Net Income Continuous | 52,377 | 45,789 | 42,277 | 33,439 | 26,158 |
| Net Income Discontinuous | -798 | 1,200 | N/A | N/A | N/A |
| Net Income | $51,579 | $46,989 | $42,277 | $33,439 | $26,158 |
| EBITDA(a) | $79,611 | $70,177 | $63,955 | $53,096 | $42,628 |